Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement: the TIRATROP Study, a Randomized Controlled Trial

NCT02505399 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT02505399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02505399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement: the TIRATROP Study, a Randomized Controlled Trial
Lead sponsor
University Hospital, Toulouse
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2015
Completion date
May 30, 2018
Enrollment
180 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis